Detailed results from two Phase 3 clinical trials of Somaxon Pharmaceuticals’ sleep aid, Silenor (doxepin), have been accepted for publication in peer-reviewed scientific journals. "These articles detail Phase 3 clinical data demons
Read MoreThe Endocrinologic and Metabolic Drugs Advisory Committee of the US Food and Drug Administration (FDA) voted against recommending approval of Vivus’ obesity drug, Qnexa. The panel voted 10–6 against recommending approval of the dru
Read MoreEmploying a tool as old as the presidency itself, President Barack Obama has named Donald M. Berwick, MD, MPP, a Harvard professor and patient care specialist, in a recess appointment as chief of the Centers for Medicare and Medicaid Services.
Read MorePhilips Respironics has launched the ComfortGel Blue nasal mask, designed to help enhance patient comfort and compliance. Retaining the comfort and flexibility features found in previous gel masks, ComfortGel Blue incorporates several
Read MoreA widespread payment probe conducted by CIGNA Government Services’ Medical Review staff showed suppliers are not following published Medicare guidelines and policies in submitting claims for necessary and reasonable HCPCS code E0601 (conti
Read More